Benzinga's Top #PreMarket Losers
March 23, 2015 at 08:15 AM EDT
MEI Pharma, Inc. (NASDAQ: MEIP) fell 62.90% to $2.33 in pre-market trading on failed Pracinostat and azacitidine Phase II study. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.